ALUR vs. VANI, ZYXI, NVNO, NSPR, CTSO, MDAI, SURG, HYPR, EDAP, and ICCM
Should you be buying Allurion Technologies stock or one of its competitors? The main competitors of Allurion Technologies include Vivani Medical (VANI), Zynex (ZYXI), enVVeno Medical (NVNO), InspireMD (NSPR), Cytosorbents (CTSO), Spectral AI (MDAI), SurgePays (SURG), Hyperfine (HYPR), EDAP TMS (EDAP), and IceCure Medical (ICCM). These companies are all part of the "medical equipment" industry.
Allurion Technologies vs. Its Competitors
Allurion Technologies (NYSE:ALUR) and Vivani Medical (NASDAQ:VANI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, valuation, dividends, profitability and analyst recommendations.
21.4% of Allurion Technologies shares are owned by institutional investors. Comparatively, 6.8% of Vivani Medical shares are owned by institutional investors. 9.6% of Allurion Technologies shares are owned by insiders. Comparatively, 46.4% of Vivani Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Vivani Medical has a net margin of 0.00% compared to Allurion Technologies' net margin of -86.05%. Allurion Technologies' return on equity of 0.00% beat Vivani Medical's return on equity.
Vivani Medical has lower revenue, but higher earnings than Allurion Technologies. Vivani Medical is trading at a lower price-to-earnings ratio than Allurion Technologies, indicating that it is currently the more affordable of the two stocks.
Allurion Technologies has a beta of -0.47, meaning that its stock price is 147% less volatile than the S&P 500. Comparatively, Vivani Medical has a beta of 2.89, meaning that its stock price is 189% more volatile than the S&P 500.
In the previous week, Allurion Technologies had 5 more articles in the media than Vivani Medical. MarketBeat recorded 6 mentions for Allurion Technologies and 1 mentions for Vivani Medical. Vivani Medical's average media sentiment score of 1.87 beat Allurion Technologies' score of 0.45 indicating that Vivani Medical is being referred to more favorably in the news media.
Allurion Technologies presently has a consensus price target of $22.83, indicating a potential upside of 694.20%. Vivani Medical has a consensus price target of $4.00, indicating a potential upside of 168.46%. Given Allurion Technologies' higher probable upside, equities analysts plainly believe Allurion Technologies is more favorable than Vivani Medical.
Summary
Allurion Technologies beats Vivani Medical on 9 of the 15 factors compared between the two stocks.
Get Allurion Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for ALUR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ALUR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Allurion Technologies Competitors List
Related Companies and Tools
This page (NYSE:ALUR) was last updated on 7/14/2025 by MarketBeat.com Staff
Free ALUR Stock Alerts